Fortnox Valuation
Is 9e+80 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 9e+80 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 9E80 (€5.19) is trading below our estimate of fair value (€5.57)
Significantly Below Fair Value: 9E80 is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 9e+80?
Other financial metrics that can be useful for relative valuation.
What is 9e+80's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | kr38.95b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 22.3x |
Enterprise Value/EBITDA | 51.6x |
PEG Ratio | 3x |
Price to Earnings Ratio vs Peers
How does 9e+80's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 40.3x | ||
AOF ATOSS Software | 53.9x | 11.1% | €2.0b |
TMV TeamViewer | 17.9x | 11.7% | €2.0b |
NEM Nemetschek | 59.3x | 15.8% | €9.6b |
MUM Mensch und Maschine Software | 30.2x | 13.0% | €896.6m |
9E80 Fortnox | 63.5x | 21.5% | €39.0b |
Price-To-Earnings vs Peers: 9E80 is expensive based on its Price-To-Earnings Ratio (63.5x) compared to the peer average (40.3x).
Price to Earnings Ratio vs Industry
How does 9e+80's PE Ratio compare vs other companies in the European Software Industry?
Price-To-Earnings vs Industry: 9E80 is expensive based on its Price-To-Earnings Ratio (63.5x) compared to the European Software industry average (32.6x).
Price to Earnings Ratio vs Fair Ratio
What is 9e+80's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 63.5x |
Fair PE Ratio | 30.6x |
Price-To-Earnings vs Fair Ratio: 9E80 is expensive based on its Price-To-Earnings Ratio (63.5x) compared to the estimated Fair Price-To-Earnings Ratio (30.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | €5.19 | €6.11 +17.7% | 24.3% | €7.52 | €2.91 | n/a | 8 |
Apr ’25 | €5.67 | €5.98 +5.3% | 25.0% | €7.65 | €2.96 | n/a | 7 |
Mar ’25 | €7.07 | €6.03 -14.6% | 25.2% | €7.87 | €3.04 | n/a | 7 |
Feb ’25 | €5.13 | €5.21 +1.5% | 23.4% | €6.52 | €2.99 | n/a | 6 |
Jan ’25 | €5.38 | €5.62 +4.6% | 15.7% | €6.54 | €3.98 | n/a | 5 |
Dec ’24 | €4.87 | €5.38 +10.7% | 17.0% | €6.43 | €3.91 | n/a | 4 |
Nov ’24 | €3.66 | €5.57 +52.1% | 19.8% | €6.69 | €3.81 | n/a | 4 |
Oct ’24 | €5.11 | €6.33 +24.0% | 9.5% | €6.84 | €5.49 | n/a | 3 |
Sep ’24 | €4.65 | €6.60 +42.1% | 8.8% | €7.21 | €5.65 | n/a | 4 |
Aug ’24 | €5.62 | €6.60 +17.4% | 8.8% | €7.21 | €5.65 | n/a | 4 |
Jul ’24 | €5.43 | €6.48 +19.3% | 10.0% | €7.22 | €5.44 | n/a | 4 |
Jun ’24 | €5.97 | €6.59 +10.4% | 10.1% | €7.32 | €5.51 | n/a | 4 |
May ’24 | €6.04 | €6.55 +8.4% | 12.1% | €7.55 | €5.33 | n/a | 4 |
Apr ’24 | €6.39 | €6.55 +2.4% | 12.1% | €7.55 | €5.33 | €5.67 | 4 |
Mar ’24 | €5.77 | €6.09 +5.6% | 9.7% | €6.98 | €5.37 | €7.07 | 4 |
Feb ’24 | €4.70 | €5.57 +18.7% | 8.2% | €6.14 | €4.96 | €5.13 | 4 |
Jan ’24 | €4.28 | €5.57 +30.2% | 8.2% | €6.14 | €4.96 | €5.38 | 4 |
Dec ’23 | €4.40 | €5.74 +30.4% | 8.9% | €6.23 | €5.04 | €4.87 | 3 |
Nov ’23 | €4.35 | €5.74 +31.9% | 8.9% | €6.23 | €5.04 | €3.66 | 3 |
Oct ’23 | €3.83 | €6.16 +60.7% | 6.8% | €6.62 | €5.61 | €5.11 | 3 |
Sep ’23 | €4.33 | €6.30 +45.7% | 6.7% | €6.81 | €5.77 | €4.65 | 3 |
Aug ’23 | €5.42 | €6.10 +12.5% | 11.0% | €6.79 | €5.19 | €5.62 | 3 |
Jul ’23 | €4.25 | €6.49 +52.7% | 13.8% | €7.35 | €5.25 | €5.43 | 3 |
Jun ’23 | €5.27 | €6.49 +23.3% | 13.8% | €7.35 | €5.25 | €5.97 | 3 |
May ’23 | €4.97 | €6.57 +32.1% | 13.8% | €7.44 | €5.31 | €6.04 | 3 |
Apr ’23 | €5.05 | €6.34 +25.5% | 13.7% | €7.44 | €5.31 | €6.39 | 3 |
Analyst Forecast: Target price is less than 20% higher than the current share price.